[HTML][HTML] Role of glioblastoma stem cells in cancer therapeutic resistance: A perspective on antineoplastic agents from natural sources and chemical derivatives

ALV Alves, INF Gomes, AC Carloni, MN Rosa… - Stem Cell Research & …, 2021 - Springer
Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most
aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior …

Cellular and molecular mechanisms of metformin: an overview

B Viollet, B Guigas, NS Garcia, J Leclerc… - Clinical …, 2012 - portlandpress.com
Considerable efforts have been made since the 1950s to better understand the cellular and
molecular mechanisms of action of metformin, a potent antihyperglycaemic agent now …

[HTML][HTML] Metabolic reprogramming in glioma

M Strickland, EA Stoll - Frontiers in cell and developmental biology, 2017 - frontiersin.org
Many cancers have long been thought to primarily metabolize glucose for energy production—
a phenomenon known as the Warburg Effect, after the classic studies of Otto Warburg in the …

[HTML][HTML] Molecular mechanisms and signaling pathways involved in sertoli cell proliferation

SB Meroni, MN Galardo, G Rindone, A Gorga… - Frontiers in …, 2019 - frontiersin.org
Sertoli cells are somatic cells present in seminiferous tubules which have essential roles in
regulating spermatogenesis. Considering that each Sertoli cell is able to support a limited …

Metformin: A review of potential mechanism and therapeutic utility beyond diabetes

S Dutta, RB Shah, S Singhal, SB Dutta… - Drug Design …, 2023 - Taylor & Francis
Metformin has been designated as one of the most crucial first-line therapeutic agents in the
management of type 2 diabetes mellitus. Primarily being an antihyperglycemic agent …

[HTML][HTML] Understanding the benefit of metformin use in cancer treatment

RJO Dowling, PJ Goodwin, V Stambolic - BMC medicine, 2011 - Springer
Biguanides have been developed for the treatment of hyperglycemia and type 2 diabetes.
Recently, metformin, the most widely prescribed biguanide, has emerged as a potential …

The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent

X Liu, RR Chhipa, I Nakano, B Dasgupta - Molecular cancer therapeutics, 2014 - AACR
AMP-activated protein kinase (AMPK) is an evolutionarily conserved energy sensor
important for cell growth, proliferation, survival, and metabolic regulation. Active AMPK …

Metformin and cancer: solutions to a real-world evidence failure

OHY Yu, S Suissa - Diabetes care, 2023 - Am Diabetes Assoc
The quest to repurpose metformin, an antidiabetes drug, as an agent for cancer prevention
and treatment, which began in 2005 with an observational study that reported a reduction in …

IAP-targeted therapies for cancer

EC LaCasse, DJ Mahoney, HH Cheung, S Plenchette… - Oncogene, 2008 - nature.com
DNA damage, chromosomal abnormalities, oncogene activation, viral infection, substrate
detachment and hypoxia can all trigger apoptosis in normal cells. However, cancer cells …

Metformin and cancer: new applications for an old drug

TV Kourelis, RD Siegel - Medical Oncology, 2012 - Springer
Metformin, one of most widely prescribed oral hypoglycemic agents, has recently received
increased attention because of its potential antitumorigenic effects that are thought to be …